• EP MedSystems (West Berlin, New Jersey) said it intends to expand the market for its Alert product platform with the submission of the Alert CS/RA premarket approval supplement to the FDA. The Alert CS/RA Catheter System replaces existing electrophysiology (EP) catheters, allowing the EP physician to not only perform routine diagnostic procedures with the patented CS/RA, but also easily cardiovert atrial fibrillation to normal heart rhythm during the procedure. The Alert system offers the advantage to cardiovert internally, via the catheter itself, without the need to interrupt the procedure for external cardioversion or the side effects associated with the use of an external defibrillator. The Alert CS/RA catheters are used in conjunction with the Alert Companion, a bi-phasic energy source manufactured by EP MedSystems.